Patents by Inventor Johan Frieling

Johan Frieling has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of antithrombin in extracorporeal membrane oxygenation
    Patent number: 9511087
    Abstract: In one aspect, the disclosure provides methods of suppressing blood clotting and/or preventing hemorrhage in a subject having extracorporeal membrane oxygenation comprising administering antithrombin. In some embodiments, the antithrombin used in the methods disclosed herein is ATryn®.
    Type: Grant
    Filed: August 2, 2013
    Date of Patent: December 6, 2016
    Assignee: rEVO Biologics, Inc.
    Inventors: Johan Frieling, Simon Lowry
  • USE OF ANTITHROMBIN IN THE TREATMENT OF PRE-ECLAMPSIA
    Publication number: 20140206617
    Abstract: In one aspect, the disclosure provides methods for the treatment of pre-eclampsia and severe pre-eclampsia comprising administering antithrombin. In some embodiments, the antithrombin used in the methods disclosed herein is ATryn®.
    Type: Application
    Filed: March 12, 2013
    Publication date: July 24, 2014
    Applicant: rEVO Biologics, Inc.
    Inventors: Johan Frieling, Simon Lowry
  • USE OF ANTITHROMBIN IN EXTRACORPOREAL MEMBRANE OXYGENATION
    Publication number: 20140194360
    Abstract: In one aspect, the disclosure provides methods of suppressing blood clotting and/or preventing hemorrhage in a subject having extracorporeal membrane oxygenation comprising administering antithrombin. In some embodiments, the antithrombin used in the methods disclosed herein is ATryn®.
    Type: Application
    Filed: August 2, 2013
    Publication date: July 10, 2014
    Applicant: rEVO Biologics, Inc.
    Inventors: Johan Frieling, Simon Lowry